Cumberland Pharmaceutical...

4.38
0.25 (6.05%)
At close: Mar 28, 2025, 3:59 PM
4.25
-2.93%
After-hours: Mar 28, 2025, 06:02 PM EDT

Cumberland Pharmaceuticals Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05
Net Income -6,443.7B -6.28M -5.65M -3.6M -3.42M -3.55M -7.04M -8.05M -1M 671.11K 2.36M -2.15M 5.81M 5.63M 2.43M 3.06M 4.77M 4.04M 4.4M 1.95M
Depreciation & Amortization 6,043.3B 5.77M 5.33M 4.61M 4.75M 4.4M 2.98M 2.65M 2.4M 2.25M 1.99M 1.3M 901.65K 1.04M 978.4K 816.5K 786.6K 762.22K 587.74K 53.54K
Stock-Based Compensation 301.89K 365.04K 447.5K 741.87K 1.05M 1.49M 1.36M 1.49M 852.1K 622.5K 761.66K 674.96K 636.53K 779.3K 688.41K 606.39K 397.5K 299.21K 104.08K n/a
Other Working Capital n/a -2.47M 644.92K -1.38M -648.84K -1.35M 552.59K -661.27K -1.17M -265.81K 162.13K 187.67K -592.15K 1.86M 1.86M -510.94K -120.77K -507.96K -1.19M 797.06K
Other Non-Cash Items -211.77B 1.6M -2.64M -3.39M -515.72K -936.54K -150.44K -65.21K 1.04M -121.72K -1.67M 154.87K -3.78M -2.22M -3.44M -2.78M -199.97K 140.62K 612.89K 474.92K
Deferred Income Tax n/a n/a n/a -192.82K 21.8K 65.41K 81.89K 4.21M 619.58K 490.23K -309.33K -1.58M -829.85K 1.67M -332.35K -525.47K 683.91K 2.23M -2.83M -1.18M
Change in Working Capital n/a 4.63M 10.97M 8.18M 3.53M 1.58M 5.87M -784.76K -3.33M 1.97M 3.56M 2.35M 4.4M 1.83M 27.45K -767.64K -37.34K 1.15M -712.61K 1.12M
Operating Cash Flow -612.19B 6.09M 8.45M 6.34M 5.42M 3.06M 3.11M -557.71K 569.48K 5.88M 6.69M 746.13K 7.14M 8.72M 346.66K 404.97K 6.4M 8.63M 2.16M 2.42M
Capital Expenditures -66.46B -453.05K -2.07M -354.46K -2.11M -1.02M -4.28M -1.49M -2.13M -2.7M -3.26M -7.56M -2.54M -437.77K -768.64K -712.34K -134.15K -163.49K -6.55M -318.5K
Acquisitions n/a n/a -13.5M n/a n/a -5M -20M 1.21M 2M 2.56M -2M 7.46M 2.07M n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments n/a n/a n/a -200K n/a -11.75M -19.57M -2.38M -5.47M -7.53M -4.21M -4.37M -21.86M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a 20.06M 16.12M 13.38M 4.49M 7.88M 3.44M 6.86M 5.22M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies 124.3B 347.36K 1.9M 52.57K 356.14K 7.54M -7.27M -1.21M -2M -2.56M -3.87M -7.46M -2.07M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow 57.84B -105.69K -13.67M -501.89K -1.76M 2.3M -27.72M 9.51M -3.12M -2.34M -6.03M -5.07M -19.18M -437.77K -768.64K -712.34K -134.15K -163.49K -6.55M -318.5K
Debt Repayment 2.49M -3.42M 1.2M n/a -3.5M -1.5M 10.2M 5.7M 2.4M 1.7M n/a -4.36M -500K -2.3M -12.67M 12.81M -39.49K -1.33M 5.06M 1.13M
Common Stock Repurchased -579.05K -740.53K -1.05M -1.39M -1.85M -3.49M -2.88M -3.72M -2.52M -5.34M -4.32M -4.8M -8.09M -4.25M -4.85M -34.77M -5M n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 196.9B -3.27M -2.21M -2.17M -1.76M -85.61K -383.31K -27.95K -1.03M -1.56M 2.65M 6.75K 4.38M 2.97M 5.13M 4.14M 479.69K -2.57M 46.75K 4.95K
Financial Cash Flow 196.9B -7.42M -2.06M -3.55M -7.12M -5.08M 7.14M 1.95M -1.15M -5.19M -1.66M -9.15M -4.21M -3.58M -12.39M 67.18M -5.25M -3.9M 5.11M 2.92M
Net Cash Flow -357.44B -1.44M -7.28M 2.29M -3.46M 273.68K -17.47M 10.9M -3.69M -1.66M -1M -13.48M -16.25M 4.71M -12.81M 66.87M 1.02M 4.56M 719.41K 5.02M
Free Cash Flow -678.65B 5.64M 6.38M 5.99M 3.3M 2.04M -1.16M -2.05M -1.56M 3.18M 3.43M -6.81M 4.6M 8.28M -421.98K -307.37K 6.26M 8.46M -4.39M 2.1M